We examined the expression levels of SLC2A1 and VEGFA in the tumor tissues of 18 lung adenocarcinoma patients by immunohistochemical staining, and the IHC results showed that high expression of SLC2A1 was significantly correlated with the increased secretion of VEGFA (Figures 7H, I). The gene discussed is SLC2A1; the disease is lung adenocarcinoma.